Comparison of the Pharmacological Effects of Dimeric Dipeptide Nerve Growth Factor Mimetic GK-2 and Mexidol on the Model of Ischemic Stroke in Rats


Цитировать

Полный текст

Открытый доступ Открытый доступ
Доступ закрыт Доступ предоставлен
Доступ закрыт Только для подписчиков

Аннотация

We compared the effects of GK-2 (dimeric dipeptide mimetic of nerve growth factor) and Mexidol (standard preparation for the therapy of stroke) on rat model of transient occlusion of the middle cerebral artery. GK-2 and Mexidol were administered intraperitoneally in the most active doses (1 and 100 mg/kg, respectively) 6 h after surgery and then once a day for 6 days. The preparations reduced the volume of cerebral infarction (by 60 and 30%, respectively). At the same time, GK-2 had a pronounced and statistically more reliable effect in a dose that is lower by two orders of magnitude. In addition, GK-2 significantly reduced the neurological deficit in the limb placement test, while Mexidol was ineffective in this test.

Об авторах

P. Povarnina

Laboratory of Peptide Bioregulation, V. V. Zakusov Research Institute of Pharmacology

Автор, ответственный за переписку.
Email: povarnina@gmail.com
Россия, Moscow

A. Volkova

Laboratory of Peptide Bioregulation, V. V. Zakusov Research Institute of Pharmacology

Email: povarnina@gmail.com
Россия, Moscow

T. Gudasheva

Laboratory of Peptide Bioregulation, V. V. Zakusov Research Institute of Pharmacology

Email: povarnina@gmail.com
Россия, Moscow

S. Seredenin

Department of Pharmacogenetics, V. V. Zakusov Research Institute of Pharmacology

Email: povarnina@gmail.com
Россия, Moscow


© Springer Science+Business Media, LLC, part of Springer Nature, 2017

Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах